NuSep Holdings (ASX:NSP) has received a Research and Development tax refund of $821,879 for its research into human and animal artificial insemination technology.
Funds will be used to further develop its SpermSep business including running clinical trials, and for working capital purposes.
The company’s technology uses proprietary polymer-based membranes and an electric field for separating high value biological substances from fluids.
This includes separating large molecules such as proteins, whole organisms such as viruses and individual cells such as spermatozoa.
Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX “Small and Mid-cap” stocks with distribution in Australia, UK, North America and Hong Kong / China.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.926M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 9869614 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 5231352 | 3 |
View Market Depth
| Last trade - 07.10am 19/09/2025 (20 minute delay) ? |
| MEM (ASX) Chart |
Day chart unavailable